Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cases of Chronic Diseases Demanding Radiation Therapy
4.2.2 Increasing Concerns over Radiation Overexposure
4.2.3 Rising Awareness and Industry Initiatives for Radiation Dose Management
4.3 Market Restraints
4.3.1 Low Adoption of radiation Dose Management Solutions in Emerging Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Products & Services
5.1.1 Standalone Solutions
5.1.2 Integrated Solutions
5.1.3 Services
5.2 By Modality
5.2.1 Computed Tomography
5.2.2 Fluoroscopy and Interventional Imaging
5.2.3 Nuclear Medicine
5.2.4 Radiography and Mammography
5.3 By End User
5.3.1 Ambulatory Care Settings
5.3.2 Hospital
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Bracco Imaging SpA
6.1.3 Fujifilm Holdings Corporation
6.1.4 GE Healthcare
6.1.5 Medsquare
6.1.6 Novarad Corporation
6.1.7 PACShealth LLC
6.1.8 Koninklijke Philips N.V.
6.1.9 Qaelum NV
6.1.10 Sectra AB


7 MARKET OPPORTUNITIES AND FUTURE TRENDS